ROCKWELL MEDICAL, INC. Payments to Acquire Available-for-sale Securities
ROCKWELL MEDICAL, INC. (RMTI) reported Payments to Acquire Available-for-sale Securities of $35.73 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2018-03-15
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for the quarter ending 2016-12-31 was $2.62M.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for the quarter ending 2016-09-30 was $13.90M, a 826.61% increase year-over-year.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for the quarter ending 2015-09-30 was $1.50M.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for fiscal 2017 was $35.73M, a 38.60% increase from fiscal 2016.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for fiscal 2016 was $25.78M, a 18.27% increase from fiscal 2015.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for fiscal 2015 was $21.80M, a 66.41% increase from fiscal 2014.
- ROCKWELL MEDICAL, INC. payments to acquire available-for-sale securities for fiscal 2014 was $13.10M, a 9.15% increase from fiscal 2013.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $35.73M 10-K · filed 2018-03-15 | |||
| 2016-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $16.52M derived: sum of 2 quarters · filed 2018-03-15 | $25.78M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $13.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $23.16M 10-Q · filed 2016-11-07 | ||
| 2016-06-30 | $9.26M 10-Q · filed 2016-08-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.50M derived: sum of 2 quarters · filed 2018-03-15 | $21.80M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $21.80M 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $20.30M 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $11.10M derived: sum of 2 quarters · filed 2017-03-15 | $11.10M derived: sum of 3 quarters · filed 2017-03-15 | $13.10M 10-K · filed 2017-03-15 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $2.00M 10-Q · filed 2015-11-09 | $4.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $2.00M 10-Q · filed 2015-08-04 | $4.00M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-03-31 | $2.00M 10-Q · filed 2015-05-07 | $4.00M derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $12.00M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $10.00M 10-Q · filed 2014-11-10 | |||
| 2012-12-31 | $12.67K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $12.67K derived: sum of 2 quarters · filed 2015-03-03 | $2.01M 10-K · filed 2015-03-03 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $2.00M 10-Q · filed 2013-11-05 | ||
| 2012-06-30 | $2.00M 10-Q · filed 2013-08-01 | |||
| 2011-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.84M derived: sum of 2 quarters · filed 2014-03-07 | $1.92M derived: sum of 3 quarters · filed 2014-03-07 | $2.00M 10-K · filed 2014-03-07 |
| 2011-09-30 | -$134.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$56.93K derived: sum of 2 quarters · filed 2012-11-09 | $24.76K 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $77.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $159.23K 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $81.69K 10-Q · filed 2012-05-07 | |||
| 2010-12-31 | $12.15M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |